Home LiteratureArticle Details
PMID: 9657 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Changes in brain norepinephrine associated with sensitization to d-amphetamine.

Psychopharmacology ·Vol. 48 ·No. 1 ·1976-07-09 ·Pages 59-67

Short PH, Shuster L

Abstract

Pretreatment of B6AF1/J mice with d-amphetamine HCl 10 mg/kg, twice daily for 5 days, produced a 4-fold increase in the running response to a test dose of 5 mg/kg amphetamine. Amphetamine pretreatment decreased whole-brain norepinephrine levels to 50% of control values and whole-brain dopamine to 85%. The test dose of 5 mg/kg amphetamine lowered whole brain norepinephrine levels of control mice from 0.50 mug/g to 0.28 mug/g in 2 h. In amphetamine-pretreated mice, this injection caused an increase in whole-brain norepinephrine levels from 0.22 mug/g to 0.55 mug/g at 30 min, followed by a decrease to 0.22 mug/g at 60 min. No change in whole brain dopamine levels was observed in either group. Amphetamine sensitization and norepinephrine depletion were still evident 25 days after pretreatment. No cross sensitization to morphine or cocaine was observed. Reserpine pretreatment resulted in a 3-fold increase in locomotor activity following injection of d-amphetamine, 5 mg/kg. No sensitization or changes in catecholamine levels were observed in amphetamine-treated A/J mice. These results suggest that the sensitization produced by amphetamine pretreatment may be related to the depletion of brain norepinephrine.

MeSH Terms
Animals Brain/metabolism Brain Chemistry/drug effects Dopamine/metabolism Male Mice Mice, Inbred Strains Motor Activity/drug effects Norepinephrine/metabolism Reserpine/pharmacology Species Specificity Tyrosine 3-Monooxygenase/metabolism
Chemicals
Reserpine Tyrosine 3-Monooxygenase Dopamine Norepinephrine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Short P H
Shuster L
References (33)
33 references, click to expand
  1. The role of biogenic amines in the extra-pyramidal system.
    Acta Physiol Pharmacol Neerl. 1969 Jun;15(2):141-54 PMID: 5799067
  2. Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes.
    Transplantation. 1971 Mar;11(3):325-7 PMID: 5558564
  3. Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine.
    J Pharmacol Exp Ther. 1968 Sep;163(1):75-83 PMID: 5673717
  4. ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.
    J Pharmacol Exp Ther. 1963 Dec;142:343-50 PMID: 14098331
  5. Urinary excretion and tissue levels of catecholamines during chronic amphetamine intoxication.
    Psychopharmacologia. 1968;13(5):394-407 PMID: 5706269
  6. Effects of d-amphetamine upon open field behaviour in two inbred strains of mice.
    Experientia. 1973 May 15;29(5):625-6 PMID: 4730313
  7. D-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo.
    J Pharmacol Exp Ther. 1975 Mar;192(3):642-53 PMID: 1120962
  8. Tolerance of rats toward amphetamine and methamphetamine.
    J Am Pharm Assoc Am Pharm Assoc. 1952 Oct;41(10):539-41 PMID: 12999608
  9. TACHYPHYLAXIS TO SOME SYMPATHOMIMETIC AMINES IN RELATION TO MONOAMINE OXIDASE.
    Br J Pharmacol Chemother. 1963 Aug;21:84-96 PMID: 14066154
  10. A comparison of the effects of d-amphetamine and morphine upon the locomotor activity of mice treated with drugs which alter brain catecholamine content.
    J Pharmacol Exp Ther. 1973 Oct;187(1):1-7 PMID: 4746328
  11. Increase in tyrosine hydroxylase activity after reserpine administration.
    J Pharmacol Exp Ther. 1969 Sep;169(1):74-9 PMID: 5804613
  12. Sensitization to amphetamines.
    Psychopharmacol Bull. 1971 Oct;7(4):30-1 PMID: 5165643
  13. A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine AND SEROTONIN IN A SINGLE BRAIN SAMPLE.
    Anal Biochem. 1968 May;23(2):196-206 PMID: 5657791
  14. Increased running response to morphine in morphine-pretreated mice.
    J Pharmacol Exp Ther. 1975 Jan;192(1):64-7 PMID: 235638
  15. Behavioral characterization of d- and l-amphetamine: neurochemical implications.
    Science. 1975 Oct 31;190(4213):475-7 PMID: 1166317
  16. The use of d-amphetamine pellet implantation as a model for d-amphetamine tolerance in the mouse.
    Psychopharmacologia. 1973 Jun 19;30(3):227-40 PMID: 4736782
  17. Potentiation of amphetamine-induced arousal by starvation.
    Nature. 1971 Oct 8;233(5319):424-5 PMID: 4940440
  18. Persistence of the effect of amphetamine on stereotyped activity in rats.
    Eur J Pharmacol. 1969 May;6(2):200-1 PMID: 5796807
  19. Effect of methamphetamine on norepinephrine metabolism in various regions of brain.
    J Pharmacol Exp Ther. 1975 Oct;195(1):87-93 PMID: 1181408
  20. Intrasynaptosomal conversion of tyrosine to dopamine as an index of brain catecholamine biosynthetic capacity.
    J Neurochem. 1974 Jun;22(6):1039-44 PMID: 4852547
  21. Effects of chronic administration of drugs which modify neurotransmitter re-uptake, storage and turnover on levels of tyrosine and tryptophan hydroxylase in rat brain.
    Biochem Pharmacol. 1974 May 1;23(9):1393-404 PMID: 4151580
  22. Effects of amphetamine on the contents of norepinephrine and its metabolites in the effluent of perfused cerebral ventricles of the cat.
    Biochem Pharmacol. 1970 Jul;19(7):2361-74 PMID: 5520379
  23. Adaptive changes in behavior after repeated administration of various psychoactive drugs.
    Adv Biochem Psychopharmacol. 1975;13:263-86 PMID: 1163377
  24. Exploratory activity: genetic analysis of its modification by scopolamine and amphetamine.
    Physiol Behav. 1973 May;10(5):893-9 PMID: 4715816
  25. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    J Pharmacol Exp Ther. 1974 Jun;189(3):717-24 PMID: 4858403
  26. Morphine-induced increases in the incorporation of 14 C-Tyrosine into 14 C-Dopamine and 14 C-norepinephrine in the mouse brain: antagonism by naloxone and tolerance.
    J Pharmacol Exp Ther. 1972 Mar;180(3):547-57 PMID: 5012782
  27. Behavioural effects in rats of morphine and amphetamine and of a combination of the two drugs.
    Psychopharmacologia. 1970;16(4):305-12 PMID: 5461437
  28. Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatum.
    Neuropharmacology. 1975 Jul;14(7):457-71 PMID: 239367
  29. Relation of thyroid function to acute and chronic effects of amphetamine in the rat.
    J Pharmacol Exp Ther. 1960 Feb;128:201-9 PMID: 13838905
  30. Chronic amphetamine treatment: vast individual differences in performing a learned response.
    Eur J Pharmacol. 1974 Dec;29(2):307-11 PMID: 4474946
  31. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
    Biochem Pharmacol. 1973 Nov 15;22(22):2801-13 PMID: 4761552
  32. The measurement of the influence of drugs on voluntary activity in mice.
    Br J Pharmacol Chemother. 1953 Mar;8(1):46-8 PMID: 13066693
  33. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Adv Biochem Psychopharmacol. 1975;13:247-62 PMID: 1171583
Article Info
Journal
Psychopharmacology
Abbr.
Psychopharmacology (Berl)
ISSN
0033-3158
Published
1976-07-09
Pages
59-67
Language
English
Region
Germany
NLM ID
7608025
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com